Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
11.040,00 GBX | -0,11% | +3,68% | +5,46% |
21/01 | AstraZeneca, Daiichi Sankyo's Datroway krijgt goedkeuring van de Amerikaanse FDA voor behandeling van gevorderde borstkanker | MT |
21/01 | ASTRAZENECA : Goldman Sachs herhaalt koopadvies | ZD |
Toevoegen aan een lijst 0 geselecteerde | Dividendrendement | Dividendrendement | K/w-verhouding | Koers-boekwaarde | EV/omzet | Beurskap. / EBITDA | Beurskap. / EBIT | Kapi. ($) | |
---|---|---|---|---|---|---|---|---|---|
+2.28% | +2.42% | 25.53x | 5.11x | 4.38x | 13.82x | 13.71x | 211 mld. | ||
+0.70% | +0.81% | 59.09x | 39.54x | 15.25x | 42.65x | 47.95x | 668 mld. | ||
+3.22% | +3.39% | 21.39x | 5x | 4.14x | 12.09x | 13.64x | 357 mld. | ||
+1.91% | +2.43% | 25.65x | 18.09x | 9.11x | 18.37x | 20.68x | 356 mld. | ||
+3.61% | +3.78% | 38.41x | 39.99x | 6.48x | 14.29x | 14.81x | 305 mld. | ||
+3.17% | +3.33% | 13.66x | 5.17x | 4.16x | 9.93x | 11.13x | 243 mld. | ||
+3.65% | +3.74% | 16.46x | 5.94x | 3.83x | 9.99x | 11.14x | 240 mld. | ||
+3.80% | +3.92% | 17.72x | 4.42x | 4.19x | 10.68x | 11.11x | 197 mld. | ||
+6.26% | +6.38% | 15.17x | 1.7x | 3.32x | 8.43x | 10.16x | 151 mld. | ||
+3.29% | +3.51% | 30.09x | 22.72x | 5.94x | 10.46x | 13.31x | 148 mld. | ||
+3.90% | +4.15% | 16.83x | 1.63x | 2.92x | 9.74x | 10.67x | 129 mld. | ||
+3.30% | +3.48% | 894.02x | 6.11x | 4.73x | 12.73x | 16.26x | 116 mld. | ||
+4.19% | +4.31% | -18.4x | 6.74x | 3.23x | 27.84x | 32.47x | 116 mld. | ||
+1.35% | +1.47% | 27.98x | 5.8x | 8.61x | 17.41x | 18.79x | 69,56 mld. | ||
+4.44% | +4.74% | 16.02x | 3.76x | 2.23x | 6.96x | 7.72x | 68,29 mld. | ||
+1.38% | +1.65% | 37.14x | 4.99x | 4.13x | 22.41x | 28.77x | 53,8 mld. | ||
+4.85% | +5.00% | 53.24x | 0.89x | 2.35x | 9.89x | 33.25x | 41,18 mld. | ||
+1.69% | +1.95% | 22.3x | 1.98x | 3.65x | 14.63x | 16.27x | 40,97 mld. | ||
+0.52% | +0.57% | 47.71x | 6.36x | 9.71x | 38.13x | 40.48x | 39,47 mld. | ||
Gemiddelde | +3,03% | +3,21% | 71,58x | 9,78x | 5,39x | 16,34x | 19,60x | 186,79 mld. | |
Gewogen gemiddelde per kap. | +2,77% | +2,96% | 57,62x | 16,36x | 7,00x | 19,08x | 21,63x |
- Beurs
- Aandelen
- Koers AZN
- Sector AstraZeneca PLC
- Sectorale dividenden